Recommendation of adjuvant trastuzumab treatment in HER-2-positive breast cancer patients: insights from quality indicator data collected in certified breast cancer centers in Germany, Italy, Austria, and Switzerland

Purpose In 2003, a certification system was introduced to ensure high standards of oncological care in breast cancer patients in Germany. Certified breast cancer centers (BCCs) must fulfill specific requirements including quality indicators (QI) derived from the clinical guidelines that are evaluate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of gynecology and obstetrics 2019-08, Vol.300 (2), p.383-388
Hauptverfasser:	Inwald, E. C., Kowalski, C., Wesselmann, S., Ferencz, J., Ortmann, O.
Format:	Artikel
Sprache:	eng
Schlagworte:	Austria Breast cancer Breast Neoplasms - diagnosis Breast Neoplasms - drug therapy Breast Neoplasms - epidemiology Breast Neoplasms - pathology Cancer therapies Certification Chemotherapy, Adjuvant - methods Documentation Endocrinology Female Germany Gynecologic Oncology Gynecology Human Genetics Humans Immunotherapy Italy Medicine Medicine & Public Health Monoclonal antibodies Obstetrics Obstetrics/Perinatology/Midwifery Patients Quality Quality control Switzerland Targeted cancer therapy Trastuzumab - pharmacology Trastuzumab - therapeutic use Treatment Outcome Tumors Values
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!